[Form 4] ANAPTYSBIO, INC Insider Trading Activity
Rhea-AI Filing Summary
AnaptysBio director John P. Schmid reported multiple stock option adjustments tied to a corporate separation. On the reported date, he received several option grants to buy AnaptysBio common stock and simultaneously disposed of corresponding options back to the issuer.
A footnote explains that, following a pro rata distribution under a Separation and Distribution Agreement between AnaptysBio and First Tracks, each existing option was split into an option for First Tracks shares and an option for AnaptysBio shares. As a result, Schmid acquired new AnaptysBio options in amounts determined under that agreement. One referenced stock option is fully vested and exercisable, while another vests in 1/12 monthly installments starting on February 6, 2026, contingent on his continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Stock Option (right to buy) | 15,000 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 15,000 | $0.00 | -- |
| Disposition | Stock Option (right to buy) | 6,000 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 6,000 | $0.00 | -- |
| Disposition | Stock Option (right to buy) | 6,000 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 6,000 | $0.00 | -- |
| Disposition | Stock Option (right to buy) | 11,000 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 11,000 | $0.00 | -- |
| Disposition | Stock Option (right to buy) | 11,000 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 11,000 | $0.00 | -- |
| Disposition | Stock Option (right to buy) | 9,200 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 9,200 | $0.00 | -- |
| Disposition | Stock Option (right to buy) | 10,600 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 10,600 | $0.00 | -- |
| Disposition | Stock Option (right to buy) | 16,510 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 16,510 | $0.00 | -- |
| Disposition | Stock Option (right to buy) | 16,510 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 16,510 | $0.00 | -- |
| Disposition | Stock Option (right to buy) | 5,500 | $0.00 | -- |
| Grant/Award | Stock Option (right to buy) | 5,500 | $0.00 | -- |
Footnotes (1)
- Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the "Separation Agreement"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement. The stock option is fully vested and exercisable. The stock option vests as to 1/12 of the total shares monthly commencing on February 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
